GenMark Diagnostics, Inc. GNMK
— —
Day range unavailable
52-week range unavailable
GNMK revenue history
Revenue is income from the company’s ordinary business activities.
171,554,000 USD
FY 2020 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | 171,554,000 | 83,533,000 | 94.90% |
| FY 2019 | 2019-12-31 | 88,021,000 | 17,262,000 | 24.40% |
| FY 2018 | 2018-12-31 | 70,759,000 | 18,240,000 | 34.73% |
| FY 2017 | 2017-12-31 | 52,519,000 | 3,245,000 | 6.59% |
| FY 2016 | 2016-12-31 | 49,274,000 | 9,863,000 | 25.03% |
| FY 2015 | 2015-12-31 | 39,411,000 | 8,817,000 | 28.82% |
| FY 2014 | 2014-12-31 | 30,594,000 | 3,190,000 | 11.64% |
| FY 2013 | 2013-12-31 | 27,404,000 | 6,935,000 | 33.88% |
| FY 2012 | 2012-12-31 | 20,469,000 | 15,460,000 | 308.64% |
| FY 2011 | 2011-12-31 | 5,009,000 | 2,445,000 | 95.36% |
| FY 2010 | 2010-12-31 | 2,564,000 | 1,565,000 | 156.66% |
| FY 2009 | 2009-12-31 | 999,000 | 351,908 | 54.38% |
| FY 2008 | 2008-12-31 | 647,092 | 305,493 | 89.43% |
| FY 2007 | 2007-12-31 | 341,599 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:10.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.